You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

TRIALODINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Trialodine patents expire, and when can generic versions of Trialodine launch?

Trialodine is a drug marketed by Quantum Pharmics and is included in one NDA.

The generic ingredient in TRIALODINE is trazodone hydrochloride. There are fourteen drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the trazodone hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Trialodine

A generic version of TRIALODINE was approved as trazodone hydrochloride by APOTEX on March 25th, 1987.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for TRIALODINE?
  • What are the global sales for TRIALODINE?
  • What is Average Wholesale Price for TRIALODINE?
Summary for TRIALODINE
Drug patent expirations by year for TRIALODINE
Recent Clinical Trials for TRIALODINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Institute on Drug Abuse (NIDA)Phase 3
Butler HospitalPhase 3

See all TRIALODINE clinical trials

US Patents and Regulatory Information for TRIALODINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Quantum Pharmics TRIALODINE trazodone hydrochloride TABLET;ORAL 070942-001 Dec 1, 1986 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

TRIALODINE Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Trazodone Hydrochloride

Introduction

Trazodone hydrochloride, a medication commonly used as an antidepressant and anxiolytic, has seen significant growth in recent years. This article delves into the market dynamics and financial trajectory of trazodone hydrochloride, highlighting key factors, trends, and projections.

Market Size and Growth

The trazodone hydrochloride market has experienced a substantial surge, with projections indicating continued significant expansion from 2023 to 2031. The market size is expected to grow robustly, driven by increasing demand for antidepressants and anxiolytics[1][4].

Segmentation

The market is segmented based on several key factors:

By Type

  • The market is categorized into different dosage strengths: 50mg, 100mg, 150mg, and 300mg. Each dosage strength has its own market share and growth trajectory[1][4].

By Application

  • Trazodone hydrochloride is primarily used as an antidepressant and anxiolytic. These applications drive the demand and influence the market dynamics[1][4].

By Geography

  • The market is analyzed across various geographical regions, including North America, Europe, Asia-Pacific, South America, and the Middle-East and Africa. Each region has its own growth rate and market size[1][4].

Market Drivers

Several factors are driving the growth of the trazodone hydrochloride market:

Increasing Prevalence of Mental Health Disorders

  • The rising prevalence of depression and anxiety disorders globally is a significant driver. As more people seek treatment, the demand for trazodone hydrochloride increases[1][4].

Growing Awareness and Acceptance

  • Increased awareness and reduced stigma around mental health issues have led to more people seeking medical help, thereby boosting the market[1].

Economic Factors

  • The economic stability and growth in certain regions have increased healthcare spending, contributing to the market's expansion[4].

Market Restraints

Despite the positive trends, there are several restraints to consider:

Side Effects and Adverse Reactions

  • Trazodone hydrochloride can have side effects such as dizziness, headache, and nausea, which may deter some patients and affect market growth[2].

Competition from Other Antidepressants

  • The presence of other antidepressants, including SSRIs and atypical antidepressants, can compete with trazodone hydrochloride for market share[2].

Market Opportunities

The market presents several opportunities for growth:

Expanding into New Markets

  • Emerging markets in Asia-Pacific and other regions offer significant potential for growth as healthcare infrastructure improves and awareness about mental health increases[1][4].

Generic and Branded Versions

  • The availability of both generic and branded versions of trazodone hydrochloride allows for a broader market reach, catering to different segments of consumers[1].

Key Players

The market is dominated by several key players:

Aurobindo Pharma, Zydus Pharmaceuticals, Accord Healthcare

  • These companies, along with others like Teva Pharmaceuticals USA, Sun Pharmaceutical Industries, and Apotex, play a crucial role in the production and distribution of trazodone hydrochloride[1].

Financial Projections

The financial trajectory of the trazodone hydrochloride market is promising:

Revenue Growth

  • The market is expected to see significant revenue growth, measured in USD million, across the forecast period from 2023 to 2031[1][4].

Market Value

  • The market value is anticipated to increase substantially, driven by the growing demand and expanding market segments[1][4].

Regional Analysis

The market performance varies across different regions:

North America and Europe

  • These regions are expected to dominate the market due to high healthcare spending and advanced healthcare infrastructure[1][4].

Asia-Pacific

  • This region is expected to show rapid growth due to increasing awareness about mental health and improving healthcare facilities[1][4].

Consumer Behavior

Consumer behavior plays a crucial role in shaping the market:

Increasing Acceptance of Mental Health Treatment

  • As more people accept and seek treatment for mental health disorders, the demand for trazodone hydrochloride increases[1].

Preference for Generic Medications

  • The preference for generic medications over branded ones can influence market dynamics, especially in cost-sensitive markets[1].

Economic, Political, and Social Landscapes

These factors significantly impact the market:

Economic Stability

  • Economic stability in various regions influences healthcare spending and, consequently, the demand for trazodone hydrochloride[4].

Healthcare Policies

  • Government policies and healthcare reforms can affect the availability and affordability of trazodone hydrochloride[4].

Social Awareness

  • Social awareness campaigns and reduced stigma around mental health issues contribute to increased demand for antidepressants and anxiolytics[1].

Technological Trends

Technological advancements can influence the market:

New Formulations

  • The development of new formulations, such as extended-release versions, can enhance patient compliance and market growth[4].

Digital Health Platforms

  • The integration of digital health platforms can improve access to mental health services and medications, including trazodone hydrochloride[4].

SWOT Analysis

A SWOT analysis provides a comprehensive view of the market's strengths, weaknesses, opportunities, and threats:

Strengths

  • Established market presence, growing demand, and diverse product offerings are key strengths[1][4].

Weaknesses

  • Side effects, competition from other antidepressants, and regulatory challenges are significant weaknesses[2].

Opportunities

  • Expanding into new markets, increasing awareness about mental health, and technological advancements are key opportunities[1][4].

Threats

  • Economic downturns, changes in healthcare policies, and competition from new medications are potential threats[4].

Key Takeaways

  • The trazodone hydrochloride market is poised for significant growth driven by increasing demand for antidepressants and anxiolytics.
  • Market segmentation by type, application, and geography highlights diverse growth trajectories.
  • Key players dominate the market, and financial projections indicate substantial revenue growth.
  • Regional analysis shows North America and Europe leading the market, with Asia-Pacific showing rapid growth.
  • Consumer behavior, economic stability, and technological trends influence market dynamics.

FAQs

Q: What are the primary applications of trazodone hydrochloride? A: Trazodone hydrochloride is primarily used as an antidepressant and anxiolytic.

Q: Which regions are expected to dominate the trazodone hydrochloride market? A: North America and Europe are expected to dominate the market, with Asia-Pacific showing rapid growth.

Q: What are the key drivers of the trazodone hydrochloride market? A: The increasing prevalence of mental health disorders, growing awareness and acceptance, and economic factors are key drivers.

Q: Who are the major players in the trazodone hydrochloride market? A: Major players include Aurobindo Pharma, Zydus Pharmaceuticals, Accord Healthcare, Teva Pharmaceuticals USA, and Sun Pharmaceutical Industries.

Q: What is the expected financial trajectory of the trazodone hydrochloride market? A: The market is expected to see significant revenue growth, measured in USD million, across the forecast period from 2023 to 2031.

Sources

  1. Market Research Intellect: Global Trazodone Hydrochloride Tablets Market Size, Trends and Forecasts 2021-2031.
  2. Agency for Healthcare Research and Quality: Treatment for Depression After Unsatisfactory Response to SSRIs.
  3. Goldman Sachs: Weighing the GLP-1 market.
  4. Cognitive Market Research: Trazodone Hydrochloride Market Report 2024 (Global Edition).

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.